STAT+: FDA rejects rare disease therapy from Disc Medicine, early recipient of commissioner’s voucher
WASHINGTON — The Food and Drug Administration on Friday rejected bitopertin, a therapy developed by Disc Medicine to treat the rare blood disorder porphyria, which makes patients extremely sensitive to sunlight. It’s the first experimental drug to go through FDA Commissi...
🔗 Read more: https://www.statnews.com/2026/02/13/disc-medicine-fda-decision/?utm_campaign=rss
#News #Medicine #Health #Psychology #Software #Finance #Science
Edited
www.statnews.com
STAT+: FDA rejects rare disease therapy from Disc Medicine, early recipient of commissioner’s voucher
WASHINGTON — The Food and Drug Administration on Friday rejected bitopertin, a therapy developed by Disc Medicine to treat the rare blood disorder porphyria, which makes patients extremely sensitive to sunlight. It’s the first experimental drug to go through FDA Commissioner Marty Makary’s new...
Comments
Log in to leave a comment.
No comments yet. Be the first to comment!